Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Goes beyond the readOnlyHint/openWorldHint annotations by disclosing the commercial model: a free daily allowance, then $0.05 USDC via x402 or 3 credits with X-API-KEY. That cost/auth disclosure is exactly the kind of context an agent needs before invoking, though it says nothing about response size or latency for a multi-section payload.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Is the description appropriately sized, front-loaded, and free of redundancy?

A single sentence with the payload contents front-loaded and the cost/auth caveat trailing in parentheses. Dense but every clause carries information; the enumeration is long yet purposeful.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a composite read tool with no output schema, enumerating the returned sections is the right substitute for documenting return values, and the billing model is covered. Remaining gap is guidance on when the aggregate is preferable to the cheaper single-purpose siblings.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Only one parameter, fully described in the schema (coverage 100%). The description's 'for one peptide' confirms the slug identifies a single peptide rather than a list, but adds no format, casing, or example detail beyond the schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Does the description clearly state what the tool does and how it differs from similar tools?

States a specific resource (one peptide's dossier) and enumerates its contents — snapshot, crosswalk, approvals, trials, FAERS, literature, citations, studies, safety — so an agent knows exactly what it returns. It doesn't explicitly contrast itself with the many single-purpose siblings (get_approvals, get_trials, get_safety...), leaving that differentiation implicit.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Does the description explain when to use this tool, when not to, or what alternatives exist?

The phrase 'in one call' implies this is the aggregator to prefer over fanning out to individual sibling tools, but the description never states that preference or names any alternative/when-not condition. Pricing text implies repeated calls should be rationed against the free daily allowance, which is weak indirect guidance.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.